Grundläggande statistik
| CIK | 1493212 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Phoenix Life Sciences International Ltd
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| November 20, 2020 |
Phoenix Life Sciences International Limited. (Form: 8-K, Received: 08/29/2019 16:31:08) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT November 16, 2020 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited (Exact name of registrant as specified in it |
|
| April 10, 2020 |
Annual Report - FORM 10-K ANNUAL REPORT Form 10-K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act July 11, 2019 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission File Number |
|
| August 29, 2019 |
PHOENIX LIFE SCIENCES INTERNATIONAL, LTD. (THE “COMPANY”) Code of Ethics Phoenix Life Sciences International Limited - 8-K Exhibit 99.4 PHOENIX LIFE SCIENCES INTERNATIONAL, LTD. (THE “COMPANY”) Code of Ethics Compliance With Law All employees, officers and directors of the Company should respect and comply with all of the laws, rules and regulations of the U.S. and other countries, and the states, counties, cities and other jurisdictions, in which the Company conducts |
|
| August 29, 2019 |
NATIONAL STORM RECOVERY, INC. (THE “COMPANY”) INSIDER TRADING POLICY Phoenix Life Sciences International Limited - 8-K Exhibit 99.5 NATIONAL STORM RECOVERY, INC. (THE “COMPANY”) INSIDER TRADING POLICY I. introduction "Insider trading" refers generally to buying or selling a security, in breach of a fiduciary duty or other relationship of trust and confidence, while in possession of material, nonpublic information about the security. Insider trading violations may a |
|
| August 29, 2019 |
Compensation Committee Charter for Phoenix Life Sciences International Ltd. Phoenix Life Sciences International Limited - 8-K Exhibit 99.3 Compensation Committee Charter for Phoenix Life Sciences International Ltd. A. PURPOSE The primary objectives of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Phoenix Life Sciences International Ltd. are to assist the Board in fulfilling its oversight responsibility by: ● working with the CEO t |
|
| August 29, 2019 |
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED AUDIT COMMITTEE CHARTER Phoenix Life Sciences International Limited - 8-K Exhibit 99.1 PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED AUDIT COMMITTEE CHARTER A. Purpose. The purpose of the Audit Committee (the “Committee”) of the Board of Directors (the “Board”) of Phoenix Sciences International Limited, a Nevada corporation (the “Company”), is to assist the Board in its oversight of (i) the integrity of the Company’s finan |
|
| August 29, 2019 |
Phoenix Life Sciences International Limited - 8-K Exhibit 99.2 PHOENIX LIFE SCIENCES INTERNATIONAL LTD. (the “Company”) Nominating Committee Charter (the “Charter”) The responsibilities and powers of this Nominating Committee (the “Committee”) as delegated by the Company’s Board of Directors (the “Board”) are set forth in this charter. Whenever the Committee takes an action, it shall exercise its |
|
| August 8, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act August 5, 2019 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| July 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act July 08, 2019 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| July 11, 2019 |
Phoenix Life Sciences International Limited 8-K Exhibit 99.1 Phoenix Life Promotes its Managing Director Janelle Marsden to CEO and Retains Strategic Advisor Tripp Keber to Drive its Global Production and Distribution Model DENVER, CO – July 8, 2019 – Phoenix Life Sciences International Limited (OTC: PLSI) (the “Company” or “Phoenix Life”), an international adaptive healthcare solutions company, t |
|
| June 28, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(D) of the Securities Exchange Act June 24, 2019 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| June 14, 2019 |
PLSI / Phoenix Life Sciences International Ltd. 8-A12G - - FORM 8-A12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Phoenix Life Sciences International Limited (Exact name of registrant as specified in its charter) Nevada 46-0525378 (State of incorporation or organization) (I. |
|
| June 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(D) of the Securities Exchange Act May 1, 2019 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| June 11, 2019 |
Phoenix Life Science International Limited 8-K Exhibit 99.2 Phoenix Life Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License DENVER, CO and Port Vila, Vanuatu – June 4, 2019 – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, the “Company”), an adaptive healthcare solutions company, today announ |
|
| May 31, 2019 |
PLSI / Phoenix Life Sciences International Ltd. NT 10-K - - NOTICE OF INABILITY TO TIMELY FILE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response…………………….2.50 SEC FILE NUMBER 333-167275 CUSIP NUMBER 71910Q102 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ¨ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: Fe |
|
| May 24, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended November 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Sci |
|
| April 25, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended August 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Scien |
|
| April 25, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended May 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Sciences |
|
| April 22, 2019 |
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 PHOENIX LIFE SCIENCES I |
|
| April 19, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended May 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Sciences |
|
| April 19, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended August 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Scien |
|
| April 19, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended November 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Sci |
|
| April 18, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended November 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Sci |
|
| April 18, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended August 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Scien |
|
| April 17, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended May 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Sciences |
|
| April 16, 2019 |
Phoenix Life Sciences International Limited 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended November 30, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number: 333-167275 Phoenix Life Sci |
|
| April 9, 2019 |
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2017 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 PHOENIX LIFE SCIENCES I |
|
| March 13, 2019 |
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 29, 2016 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 PHOENIX LIFE SCIENCES |
|
| March 4, 2019 |
MJMD / MediJane Holdings Inc. ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) (Mark One) ☒ . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2015 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 M |
|
| December 10, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act November 28, 2018 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| December 10, 2018 |
Phoenix Life Sciences International Limited 8-K Exhibit 99.1 Phoenix Life Sciences International Announces Angus Stewart as Company’s New Agriculture and Horticulture Senior Advisor DENVER, CO – November 28, 2018 – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Angus Stewart has joined the compa |
|
| December 10, 2018 |
EX-99.2 3 ex99-2.htm PRESS RELEASE Phoenix Life Sciences International Limited 8-K Exhibit 99.2 Phoenix Life Sciences International Announces the Release of the Company’s Investor Relations Deck and Accompanying Video Presentation DENVER, CO – December 6, 2018 – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today a |
|
| November 23, 2018 |
Phoenix Life Sciences International Limited 8-K Exhibit 99.3 Phoenix Life Sciences Receives Import Certificate for Cannabis Diabetes Drug from the Republic of Vanuatu DENVER - November 07, 2018 - Phoenix Life Sciences International Limited (OTCMarkets: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has received an import certificate from the |
|
| November 23, 2018 |
Phoenix Life Sciences International Limited 8-K Phoenix Life Sciences International Limited 8-K Exhibit 99.2 Phoenix Life Sciences International Announces Significant Retirement of Convertible Debt and Elimination of Outstanding Preferred Shares DENVER , Nov. 13, 2018 (GLOBE NEWSWIRE) — Phoenix Life Sciences International Limited (“Phoenix Life”) (OTC: PLSI), an international adaptive healthcare solutions company, today announced that it has re |
|
| November 23, 2018 |
Phoenix Life Sciences International Limited 8-K EX-99.1 2 ex99-1.htm PRESS RELEASE ISSUED NOVEMBER 1, 2018 Phoenix Life Sciences International Limited 8-K Exhibit 99.1 Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses DENVER – November 2, 2018 – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions |
|
| November 23, 2018 |
8-K 1 plsi-8k110118.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act November 1, 2018 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or |
|
| October 3, 2018 |
Phoenix Life Sciences International Limited 8-K Phoenix Life Sciences International Limited 8-K Exhibit 99.1 Phoenix Life Sciences International Announces New Board of Directors and Executive Team DENVER – October 3, 2018 – Phoenix Life Sciences International Limited (OTCMarkets: MJMD) (“Phoenix Life”), an adaptive healthcare solutions company, today announced its new Board of Directors and executive team. “We have strategically selected these |
|
| October 3, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act October 1, 2018 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| September 24, 2018 |
Phoenix Life Sciences International Limited 8-K Exhibit 99.1 Phoenix Life Sciences International Announces Significant Milestones in Company Merger and Fiscal Structure-Strategy DENVER – September XX, 2018 – Phoenix Life Sciences International Limited (“Phoenix Life”) (OTCMarkets: MJMD), an adaptive global healthcare solutions company, today provided an update on the completion of merger documents |
|
| September 24, 2018 |
Phoenix Life Sciences International Limited. 8-K Exhibit 2.1 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (“Agreement”) is made this 18th day of September, 2018 (“Execution Date” or “Closing Date”), Phoenix Life Sciences International Limited, a Canada (BC) Company (hereinafter “Phoenix Life”) and Phoenix Life Sciences International, Limited. (FKA Stem Bioscience, Inc.), a Nevada |
|
| September 24, 2018 |
Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act September 21, 2016 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| September 21, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act January 25, 2016 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| September 18, 2018 |
Amendment to Articles of Incorporation filed with the Secretary of State of Nevada. EX-3.1 2 ex3-1.htm AMENDMENT TO ARTICLES OF INCORPORATION Phoenix Life Sciences International Limited. 8-K Exhibit 3.01 |
|
| September 18, 2018 |
Phoenix Life Sciences International Limited. 8-K Phoenix Life Sciences International Limited. 8-K Exhibit 99.1 Phoenix Life Sciences International Completes Merger and Announces Global Production Strategy DENVER – September 18, 2018 – Phoenix Life Sciences International Limited (“Phoenix Life”), an adaptive healthcare solutions company, today announced its common stock is now publicly traded in the United States, trading under the symbol OTC: MJ |
|
| September 18, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act May 31, 2018 Date of Report (Date of Earliest Event Reported) Phoenix Life Sciences International Limited. |
|
| February 26, 2018 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* Medijane Holdings, Inc. (Name of Issuer) common shares, par value of $0.001 per share (Title of Class of Securities) 58471E206 (CUSIP Number) Calendar Year 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange Act of 1934 (Amendment 1) MediJane Holdings Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58471E206 (CUSIP Number) October 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| April 18, 2016 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Medijane Holdings, Inc. (Name of Issuer) common shares, par value of $0.001 per share (Title of Class of Securities) 58471E206 (CUSIP Number) April 18, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| April 8, 2016 |
PLSI / Phoenix Life Sciences International Ltd. / KCG AMERICAS LLC - SC 13G MJMD Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G (Initial Filing) Under the Securities Exchange Act of 1934 MediJane Holdings Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58471E206 (CUSIP Number) March 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 22, 2016 |
MediJane Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act February 17, 2016 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| January 19, 2016 |
MediJane Holdings FORM 10-Q (Quarterly Report) 10-Q 1 medijane10q2q15v11.htm FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [x] Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended August 31, 2015 -OR- [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from to Commission File Number - 33 |
|
| January 14, 2016 |
MediJane Holdings FORM NT 10-Q MediJane Holdings Inc. NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 333-167275 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR For Period Ended: November 30, 2015 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report o |
|
| January 14, 2016 |
MediJane Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act January 13, 2016 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| November 18, 2015 |
MediJane Form 8-K/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K /A Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act July 31, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| November 17, 2015 |
MediJane Holdings REGISTRATION WITHDRAWAL MediJane registration withdrawal MediJane Holdings Inc. 2770 Arapahoe Road, Suite 132, PMB 150 Lafayette, CO 80026 (855) 933-3499 Application for Withdrawal of Registration Statement November 16, 2015 U.S. Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Re: MediJane Holdings Inc. Registration Statement on Form S-1 Filed October 29, 2014, as amended March 2 |
|
| November 9, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant MediJane Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K /A Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act October 26, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| November 2, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 medijane8k401103015.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act October 26, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction of incorporation |
|
| October 22, 2015 |
MediJane Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act October 22, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| October 15, 2015 |
MediJane Holdings FORM NT 10-Q MediJane NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 333-167275 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR For Period Ended: August 31, 2015 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Tr |
|
| September 16, 2015 |
Exhibit 10.1 |
|
| September 16, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits MediJane Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act August 17, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| September 11, 2015 |
Exhibit 10.1 |
|
| September 11, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits MediJane Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act July 31, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| August 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K /A (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K /A (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2015 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 MEDIJANE HOLDINGS |
|
| August 28, 2015 |
MEDIJANE HOLDINGS INC. 2014 STOCK AWARDS PLAN MEDIJANE HOLDINGS INC. 2014 STOCK AWARDS PLAN 1. Purpose. The purpose of the MediJane Holdings Inc. 2014 Stock Awards Plan is to provide a means through which MediJane Holdings Inc., a Colorado corporation, and its subsidiaries, if any, may attract, retain and motivate employees, directors and persons affiliated with the Company, including, but not limited to, non-employee consultants, and to prov |
|
| August 28, 2015 |
NEW PRODUCT DEVELOPMENT ADVISORY SERVICES AGREEMENT NEW PRODUCT DEVELOPMENT ADVISORY SERVICES AGREEMENT Effective September 2, 2014, MediJane Holdings, Inc. |
|
| August 10, 2015 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [x] Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended May 31, 2015 -OR- [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from to Commission File Number - 333-167275 MediJane Holdings Inc. (Exact name |
|
| July 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2015 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 MEDIJANE HOLDINGS INC |
|
| July 14, 2015 |
MediJane Holdings FORM NT 10-Q MediJane Form NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 27, 2015 |
MediJane Holdings FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 333-167275 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR For Period Ended: February 28, 2015 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report |
|
| March 20, 2015 |
Registration No. 333-199652 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MediJane Holdings Inc. (Exact name of registrant as specified in its charter) Nevada 5122 46-0525378 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code) (I.R.S. Employer Identification No. |
|
| March 20, 2015 | ||
| March 20, 2015 |
The following are the wholly owned subsidiaries of MediJane Holdings, Inc.: The following are the wholly owned subsidiaries of MediJane Holdings, Inc.: - MediSales (CA), Inc. - MediHoldings, Inc. |
|
| March 20, 2015 |
EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”), effective as of March 16, 2014 (the “Effective Date”), is made by and between MediJane Holdings, Inc. |
|
| March 9, 2015 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q /A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q /A [x] Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended November 30, 2014 -OR- [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from to Commission File Number - 333-167275 MediJane Holdings Inc. (Ex |
|
| February 19, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act February 18, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| February 10, 2015 | ||
| February 10, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act January 15, 2015 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| January 20, 2015 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [x] Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended November 30, 2014 -OR- [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from to Commission File Number - 333-167275 MediJane Holdings Inc. (Exact |
|
| January 13, 2015 |
PLSI / Phoenix Life Sciences International Ltd. NT 10-Q - - FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 333-167275 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR For Period Ended: November 30, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report |
|
| January 8, 2015 | ||
| January 8, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act November 19, 2014 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| January 8, 2015 | ||
| January 8, 2015 |
STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. |
|
| November 25, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q /A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q /A [x] Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended August 31, 2014 -OR- [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from to Commission File Number - 333-167275 MediJane Holdings Inc. (Exac |
|
| October 29, 2014 |
PLSI / Phoenix Life Sciences International Ltd. S-1 - Registration Statement - FORM S-1 Registration No. 333-167275 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MediJane Holdings Inc. (Exact name of registrant as specified in its charter) Nevada 5122 46-0525378 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code) (I.R.S. Employer Identification No. |
|
| October 20, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [x] Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended August 31, 2014 -OR- [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from to Commission File Number - 333-167275 MediJane Holdings Inc. (Exact n |
|
| October 15, 2014 |
PLSI / Phoenix Life Sciences International Ltd. NT 10-Q - - 10-Q EXTENSION REQUEST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 333-167275 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR For Period Ended: August 31, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report o |
|
| September 23, 2014 |
EX-10.1 2 securitiespurchaseagreementm.htm EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT Dated as of September 16, 2014 among MEDIJANE HOLDINGS INC. and THE PURCHASERS LISTED ON EXHIBIT A TABLE OF CONTENTS Page ARTICLE I Purchase and Sale of Common Stock and Warrants ...................................................1 Section 1.1 Purchase and Sale of Common Stock and Warrants........................ |
|
| September 23, 2014 |
Headline MediJane Holdings completes equity financing through its investment banking firm, Moody Capital Longmont, Colorado - September 22, 2014 - MediJane Holdings Inc. |
|
| September 23, 2014 |
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 16, 2014, by and among MediJane Holdings Inc. |
|
| September 23, 2014 |
EX-10.3 5 lockupagreements.htm EXHIBIT 10.3 |
|
| September 23, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act September 17, 2014 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| September 22, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act September 17, 2014 Date of Report (Date of Earliest Event Reported) MediJane Holdings Inc. |
|
| July 21, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [x] Quarterly Report Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 for Quarterly Period Ended May 31, 2014 -OR- [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities And Exchange Act of 1934 for the transaction period from to Commission File Number - 333-167275 MediJane Holdings Inc. (Exact name |
|
| July 17, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act July 15, 2014 Date of Report (Date of Earliest Event Reported) MediJane Holdings, Inc. |
|
| July 16, 2014 |
SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 24, 2014, is entered into by and between MEDIJANE HOLDINGS, INC. |
|
| July 16, 2014 |
SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Agreement”), dated as of June 24, 2014, is executed by MediJane Holdings, Inc. |
|
| July 16, 2014 |
[Signature Page to Membership Interest Pledge Agreement] MEMBERSHIP INTEREST PLEDGE AGREEMENT This MEMBERSHIP INTEREST PLEDGE AGREEMENT (this “Agreement”) is entered into as of June 24, 2014 (the “Effective Date”) by and between MEDIJANE HOLDINGS, INC. |
|
| July 16, 2014 |
[Signature Page to Warrant] NOTICE OF EXERCISE OF WARRANT THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. |
|
| July 16, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act June 24, 2014 Date of Report (Date of Earliest Event Reported) MediJane Holdings, Inc. |
|
| July 16, 2014 |
[Signature Page to Secured Convertible Promissory Note] ATTACHMENT 1 SECURED CONVERTIBLE PROMISSORY NOTE Effective Date: June 24, 2014 U.S. $1,105,000.00 FOR VALUE RECEIVED, MEDIJANE HOLDINGS, INC., a Nevada corporation (“Borrower”), promises to pay to TYPENEX CO-INVESTMENT, LLC, a Utah limited liability company, or its successors or assigns (“Lender”), $1,105,000.00 and any interest, fees, charges, and late fees on the date that is twenty-three (23) months after t |
|
| July 15, 2014 |
MJMD / MediJane Holdings Inc. NT 10-Q - - FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 333-167275 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR For Period Ended: May 31, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on F |
|
| June 18, 2014 |
Unregistered Sales of Equity Securities - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 11, 2014 MEDIJANE HOLIDNGS, INC. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2014 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 MEDIJANE HOLDINGS INC |
|
| May 29, 2014 |
MediJane Announces First MediStrips Purchase Order From GoKush.com in California MediJane Announces First MediStrips Purchase Order From GoKush.com in California LONGMONT, CO, May 27, 2014 (Marketwired via COMTEX) - MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company") is pleased to announce that it has received its first wholesale purchase order for the recently launched "MediStrips - Relaxation" dissolvable oral strips. The order is for an initial 15,0 |
|
| May 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 333-167275 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR For Period Ended: February 28, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report |
|
| May 29, 2014 |
Financial Statements and Exhibits, Other Events 8-K 1 f140529medijaneform8kitems80.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 27, 2014 MEDIJANE HOLDINGS INC. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other |
|
| May 22, 2014 |
May 22, 2014 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Re: MEDIJANE HOLDINGS INC. Dear Sirs/Madams: We have read Item 4.01 of the Current Report on Form 8-K dated May 22, 2104 (date of event May 21, 2014) of MEDIJANE HOLDINGS INC., and we agree with the statements made therein concerning our firm. Very truly yours, /s/ Goldman Accounting Services CPA, PLLC G |
|
| May 22, 2014 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act May 21, 2014 Date of Report (Date of Earliest Event Reported) MediJane Holdings, Inc. |
|
| May 20, 2014 |
LICENSE AGREEMENT This LICENSE AGREEMENT (the "Agreement") is made as of March 14, 2014 (the "Effective Date") by and between MediJane Holdings, Inc. |
|
| May 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 14, 2014 MEDIJANE HOLIDNGS, INC. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 20, 2014 |
AGREEMENT This Agreement ("Agreement") is made and entered into as of this 13 day of March 2014, by and between South Pacific Resources, Inc. |
|
| May 2, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act April 16, 2014 Date of Report (Date of Earliest Event Reported) MediJane Holdings, Inc. |
|
| March 20, 2014 |
EX-10.1 2 f8k032014ex10z1.htm EXHIBIT 10.1 LICENSE AGREEMENT Exhibit 10.1 |
|
| March 20, 2014 |
FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 17, 2014 |
Exhibit 10.1 Stock Purchase Agreement Exhibit 10.1 |
|
| March 17, 2014 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 10, 2014 |
Exhibit 3.2 Certificate of Correction Exhibit 3.2 |
|
| March 10, 2014 |
Financial Statements and Exhibits, Other Events - FORM 8-K CURRENT REPORT Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 10, 2014 |
EX-3.1 2 f8k031014ex3z1.htm EXHIBIT 3.1 CERTIFICATE OF AMENDMENT Exhibit 3.1 |
|
| March 6, 2014 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 5, 2014 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 21, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q FORM 10-Q Quarterly Report November 30 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 21, 2014 |
SUBSCRIPTION AGREEMENT (Offshore Subscribers) Exhibit 10.6 Convertible Note Exhibit 10.6 THIS SUBSCRIPTION AGREEMENT RELATES TO AN OFFERING OF A CONVERTIBLE NOTE (THE “NOTE”) IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). THE NOTE TO WHICH THIS SUBSCRIPTION AGREEMENT (THE “SUBSCRIPTION AGREEMENT”) RELATES H |
|
| January 15, 2014 |
- FORM 12B-25 NOTIFICATION OF LATE FILING Form 12b-25 Notification of Late Filing U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-167275 CUSIP NUMBER . Form 10-K . Form 20-F . Form 11-K X . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For period ended: November 30, 2013 . Transition Report on Form 10-K . Transition Report on Form 20-F . Transition Report on Form |
|
| October 21, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2013 Or . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-167275 MOKITA, INC. |
|
| October 17, 2013 |
CORRESP 1 filename1.htm MOKITA, INC. 7695 SW 104th St., Suite 210 Miami, Florida, 33156 October 16, 2013 VIA EDGAR Securities and Exchange Commission 100 F. Street, NE Washington, D.C. 20549-7410 Attention: Ethan Horowitz Branch Chief Dear , Mesdames: Re: Mokita, Inc. (the “Company”) Form 10-K for Fiscal Year Ended February 28, 2013 Filed June 13, 2013 File No. 333-167275 Further to our correspond |
|
| October 16, 2013 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant FORM 8-K/A Amended Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 16, 2013 |
Exhibit 16.1 Letter to the SEC EXHIBIT 16.1 October 16, 2013 U.S. Securities and Exchange Commission 450 – Fifth Street N. W. Washington, DC 20549 Re: Mokita, Inc. Ladies and Gentlemen: We have read the statements under item 4.01 in the Form 8-K dated October 16, 2013, of Mokita, Inc. (the Company) to be filed with the Securities and Exchange Commission and we agree with such statements therein as |
|
| October 16, 2013 |
- FORM 12B-25 NOTIFICATION OF LATE FILING Form 12b-25 Notification of Late Filing U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-167275 CUSIP NUMBER . Form 10-K . Form 20-F . Form 11-K X . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For period ended: August 31, 2013 . Transition Report on Form 10-K . Transition Report on Form 20-F . Transition Report on Form 1 |
|
| October 1, 2013 |
Changes in Registrant's Certifying Accountant 8-K 1 f8kno21001138k.htm CURRENT REPORT ON FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 28, 2013 MOKITA, INC. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisd |
|
| October 1, 2013 |
Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 1, 2013 |
Exhibit 3.1 Certificate of Change |
|
| August 9, 2013 |
Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2013 Or . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-167275 MOKITA, INC. (E |
|
| June 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2013 . . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 M |
|
| June 13, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2013 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-167275 MOKITA, INC. (Exact n |
|
| June 5, 2013 |
Exhibit 3.1 Certificate of Amendment Exhibit 3.1 |
|
| June 5, 2013 |
Financial Statements and Exhibits, Other Events - FORM 8-K CURRENT REPORT FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 30, 2013 |
- FEBRUARY 28, 2013 10-K EXTENSION February 28, 2013 10-K Extension UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2012 Or . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-167275 MOKITA VENTURES |
|
| April 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2012 or . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-167275 MOKITA VENTU |
|
| April 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2012 Or . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-167275 MOKITA VEN |
|
| December 20, 2012 |
8-K 1 f8k1220128k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 14, 2012 MOKITA VENTURES, INC. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or othe |
|
| October 12, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 f10k02291210k.htm FORM 10-K ANNUAL REPORT FEBRUARY 29 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 29, 2012 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition peri |
|
| May 30, 2012 |
- EXTENSION FOR FEBRUARY 29, 2012 10-K Extension for February 29, 2012 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 23, 2012 |
SUBSCRIPTION AGREEMENT (Offshore Subscribers) Exhibit 10.1 Convertible Debenture Exhibit 10.1 THIS SUBSCRIPTION AGREEMENT RELATES TO AN OFFERING OF A CONVERTIBLE NOTE (THE “NOTE”) IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). THE NOTE TO WHICH THIS SUBSCRIPTION AGREEMENT (THE “SUBSCRIPTION AGREEMENT”) RELA |
|
| March 23, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 15, 2012 MOKITA VENTURES, INC. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction of incorporation) (Commis |
|
| March 12, 2012 |
8-K 1 f8k0309128k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 8, 2012 MOKITA VENTURES, INC. (Exact name of registrant as specified in its charter) Nevada 333-167275 46-0525378 (State or other ju |
|
| February 16, 2012 |
FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 23, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 quarterlyreport10q.htm FORM 10-Q QUARTERLY REPORT NOVEMBER 30 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X . QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2011 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commissio |
|
| January 17, 2012 |
- FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-167275 CUSIP NUMBER 60845P 107 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING . Form 10-K . Form 20-F . Form 11-K X . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For period ended: November 30, 2011 . Transition Report on Form 10-K . Transition Report on Form 20-F . Transition Report on Form 11-K . Transition Report on |
|
| October 31, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A X . QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2011 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 333-167275 MOKITA VENTURES, INC. (Name of small business iss |
|
| October 24, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X . QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2011 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 333-167275 MOKITA VENTURES, INC. (Name of small business issue |
|
| October 17, 2011 |
U.S. SECURITIES AND EXCHANGE COMMISSION U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 333-167275 FORM 12b-25 CUSIP NUMBER 60845P 107 NOTIFICATION OF LATE FILING . Form 10-K . Form 20-F . Form 11-K X . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For period ended: August 31, 2011 . Transition Report on Form 10-K . Transition Report on Form 20-F . Transition Report on Form 11-K . Transition Report on Fo |
|
| September 22, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 29, 2011 MOKITA VENTURES, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission File Number) (IRS Em |
|
| July 27, 2011 |
8-K 1 mokita8k072711.htm CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 20, 2011 MOKITA VENTURES, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission |
|
| July 22, 2011 |
EX 3.01(b) Exhibit 3.01(b) |
|
| July 22, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 22, 2011 MOKITA VENTURES, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorpora |
|
| July 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X . QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2011 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-167275 MOKITA, INC. (Exact name of registrant as spec |
|
| June 28, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 21, 2011 MOKITA, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction of Incorporation) (Commission File Number) (IRS Employer Ide |
|
| June 28, 2011 |
Child, Van Wagoner and Bradshaw, PLLC Exhibit 16.1 Exhibit 16.1 Child, Van Wagoner and Bradshaw, PLLC 5296 South Commerce Drive, Suite 300 Salt Lake City, Utah 84107-5370 (801) 281-4700 June 22, 2011 Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Ladies and Gentlemen: The firm of Child, Van Wagoner and Bradshaw, PLLC was previously principal accountant for Mokita, Inc., (the "Company") and reported on the f |
|
| June 14, 2011 |
Exhibit 10.04 |
|
| June 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended February 28, 2011 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to MOKITA, INC. (Exact name of registrant as specified in its charter) |
|
| June 8, 2011 |
EX 10.1 Exhibit 10.1 |
|
| June 8, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 31, 2011 MOKITA, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorporation) Iden |
|
| May 31, 2011 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-167275 X . Form 10-K . Form 20-F . Form 11-K . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For period ended: February 28, 2011 . Transition Report on Form 10-K . Transition Report on Form 20-F . Transition Report on Form 11-K . Transition Report on Form 10-Q . Transition |
|
| May 16, 2011 |
Exhibit 10.1 Exhibit 10.1 BUCKEYE EXPLORATION COMPANY 2011 DRILLING PROGRAM SOUTHWEST OTOE CITY PROSPECT PARTICIPATION AGREEMENT MOKITA, INC. NAME (As will be shown on Assignments of Interest and for record title) 7695 S.W. 104th Street, Suite 210 Miami FL 33156 ADDRESS CITY STATE ZIP (305) 663-1466 (305) 668-0003 PHONE FAX [email protected] E-MAIL SS# or TAX ID# Agrees to purchase a total of 6% wo |
|
| May 16, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 12, 2011 MOKITA, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorporation) Iden |
|
| March 30, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 29, 2011 MOKITA, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorporation) Id |
|
| March 23, 2011 |
8-K 1 eightk.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2011 MOKITA, INC. (Exact name of Company as specified in its charter) Nevada 333-167275 46-0525378 (State or other jurisdiction (Commission File Number) (IRS |
|
| January 6, 2011 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mokita 10Q 11-30-10 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 333-167275 MOK |
|
| October 15, 2010 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 333-167275 MOKITA, INC. (Exact name |
|
| September 8, 2010 |
424B2 1 prospectus.htm PROSPECTUS . Prospectus MOKITA, INC. Date of Prospectus: September 3, 2010 (Subject To Completion) 10,000,000 Shares of Common Stock $0.01 per share This is a public offering of 10,000,000 shares of Common Stock of Mokita, Inc. (Mokita). Our sole officer and director will market our common stock and offer and sell the securities on our behalf. This is a best efforts direct p |
|
| September 3, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Amendment #3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOKITA, INC. Nevada 6199 46-0525378 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 11420 - - 142 Street NW Edmonton, AB, T5M-1V1 Telephone: (78 |
|
| August 23, 2010 |
MOKITA, INC. 11420 – 142 Street NW Edmonton, AB T5M – 1V1 (780) 08-4962 MOKITA, INC. 11420 – 142 Street NW Edmonton, AB T5M – 1V1 (780) 08-4962 VIA FASCIMILE (202-551-3234) AND EDGAR CORRESPONDENCE August 23, 2010 Michael Clampitt Division of Corporation Finance Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Re: Mokita, Inc. Registration Statement on Form S-1/A Filed August 17, 2010 File No. 333-167275 Dear Mr. Clampitt, Please consider this a |
|
| August 17, 2010 |
PARSONS/BURNETT/BJORDAHL LLP ATTORNEYS James B. Parsons [email protected] VIA FACSIMILE (703-813-6983) August 16, 2010 Mr. Michael Clampitt Senior Attorney US Securities Exchange Commission Division of Corporation Finance 100 F Street NE Washington, DC 20549 Re: Mokita, Inc. Registration Statement on Form S-1/A Filed July 15, 2010 File No. 333-167275 Dear Mr. Clampitt: This letter is in response |
|
| August 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Amendment #2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOKITA, INC. Nevada 6199 46-0525378 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 11420 - 142 Street NW Edmonton, AB, T5M-1V1 Telephone: (780) |
|
| July 12, 2010 |
PARSONS/BURNETT/BJORDAHL LLP ATTORNEYS James B. Parsons [email protected] VIA FACSIMILE (703-813-6983) July 12, 2010 Mr. Michael Clampitt Senior Attorney US Securities Exchange Commission Division of Corporation Finance 100 F Street NE Washington, DC 20549 Re: Mokita, Inc. Registration Statement on Form S-1 Filed June 3, 2010 File No. 333-167275 Dear Mr. Clampitt: This letter is in response to yo |
|
| July 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Amendment #1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOKITA, INC. Nevada 6199 46-0525378 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 11420 - 142 Street NW Edmonton, AB, T5M-1V1 Telephone: (780) |
|
| July 12, 2010 |
SUBSCRIPTION AGREEMENT TO: I hereby agree to become a shareholder of Mokita, Inc., a Nevada corporation (the “Company”), and to purchase the number of Shares of the Company (the “Shares”), as set forth above my signature hereto at a purchase price of $.01 per Share. Simultaneously with the execution and delivery hereof, I am transmitting a certified or bank check, money order or bank wire to the o |
|
| June 3, 2010 | ||
| June 3, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOKITA, INC. Nevada 6199 46-0525378 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 11420 - - 142 Street NW Edmonton, AB, T5M-1V1 Telephone: (780) 708-4962 C |
|
| June 3, 2010 |
BYLAWS MOKITA EXPLORATION LTD. SECTION 1 SHAREHOLDERS' AND SHAREHOLDERS' MEETINGS BYLAWS OF MOKITA EXPLORATION LTD. SECTION 1 SHAREHOLDERS' AND SHAREHOLDERS' MEETINGS 1.1 Annual Meeting. The annual meeting of the shareholders of this corporation (the "Corporation") for the election of directors and for the transaction of such other business as may properly come before the meeting shall be held each year at the principal office of the corporation, or at some other place either w |
|
| June 3, 2010 |
EX-3.1 2 ex31articlesofincorporation.htm ARTICLES OF INCORPORATION |
